Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 11, 2015, Pages 1382-1388

  Colussi, Dora ^a   Salari, Behzad ^a   Stewart, Kathleen O ^a   Lauwers, Gregory Y ^a   Richter, James R ^a   Chan, Andrew T ^a   Ricciardiello, Luigi ^b   Khalili, Hamed ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bismuth subsalicylate; Budesonide; Cholestyramine; Collagenous colitis; Loperamide; Lymphocytic colitis; Microscopic colitis; Treatment patterns and response

Indexed keywords

BISMUTH SALICYLATE; BUDESONIDE; COLESTYRAMINE; LOPERAMIDE; MESALAZINE; ANTIINFLAMMATORY AGENT; BISMUTH; ORGANOMETALLIC COMPOUND; SALICYLIC ACID DERIVATIVE;

ABDOMINAL PAIN; ADULT; ARTICLE; CHI SQUARE TEST; COLLAGENOUS COLITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FISHER EXACT TEST; HUMAN; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; PRIORITY JOURNAL; RANK SUM TEST; SMOKING; TERTIARY CARE CENTER; TREATMENT RESPONSE; WEIGHT REDUCTION; AGE; AGED; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; MIDDLE AGED; STATISTICAL MODEL; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BISMUTH; BUDESONIDE; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; SALICYLATES; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84945178860     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2015.1050692     Document Type: Article

References (27)

1. Brown WR, Tayal S. Microscopic colitis. A review. J Dig Dis 2013;14:277-81.
2. Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology 2011;140:1155-65.
3. Kao KT, Pedraza BA, McClune AC, Rios DA, Mao YQ, Zuch RH, et al. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol 2009;15:3122-7.
4. Fernandez-Banares F, Esteve M, Espinos JC, Rosinach M, Forné M, Salas A, et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 2007;102:324-30.
5. Fine KD, Do K, Schulte K, Ogunji F, Guerra R, Osowski L, et al. High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am J Gastroenterol 2000; 95:1974-82.
6. Riddell RH, Tanaka M, Mazzoleni G. Non-steroidal antiinflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut 1992;33:683-6.
7. Sonnenberg A, Genta RM. Lymphocytic and collagenous colitis: epidemiologic differences and similarities. Dig Dis Sci 2013;58:2970-5.
8. Baert F, Schmit A, D'Haens G, Dedeurwaerdere F, Louis E, Cabooter M, et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002;122:20-5.
9. Bonderup OK, Hansen JB, Birket-Smith L, Vestergaard V, Teglbjaerg PS, Fallingborg J. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 2003;52: 248-51.
10. Bonderup OK, Hansen JB, Teglbjaerg PS, Christensen LA, Fallingborg JF. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebocontrolled trial. Gut 2009;58:68-72.
11. Madisch A, Heymer P, Voss C, Wigginghaus B, Bästlein E, Bayerdörffer E, et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis 2005;20:312-16.
12. Miehlke S, Heymer P, Bethke B, Bästlein E, Meier E, Bartram HP, et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002;123:978-84.
13. Miehlke S, Madisch A, Bethke B, Morgner A, Kuhlisch E, Henker C, et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2008;135:1510-16.
14. Miehlke S, Madisch A, Voss C, Morgner A, Heymer P, Kuhlisch E, et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther 2005;22:1115-19.
15. Tromm A, Griga T, Mollmann HW, May B, Muller KM, Fisseler-Eckhoff A. Budesonide for the treatment of collagenous colitis: first results of a pilot trial. Am J Gastroenterol 1999;94:1871-5.
16. Munck LK, Kjeldsen J, Philipsen E, Fischer Hansen B. Incomplete remission with short-term prednisolone treatment in collagenous colitis: a randomized study. Scand J Gastroenterol 2003;38:606-10.
17. Miehlke S, Madisch A, Kupcinskas L, Petrauskas D, Böhm G, Marks HJ, et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology 2014;146:1222-30; e1221-1222.
18. Fine KOF, Lee E, Lafon G, Tanzi M. Randomized, doubleblind, placebo-controlled trial of bismuth subsalicylate for microscopic colitis. Gastroenterology 1999;116:A880.
19. Munch A, Aust D, Bohr J, Bonderup O, Fernández Bañares F, Hjortswang H, et al. Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohn's Colitis 2012;6:932-45.
20. Munch A, Ignatova S, Strom M. Adalimumab in budesonide and methotrexate refractory collagenous colitis. Scand J Gastroenterol 2012;47:59-63.
21. Giardiello FM, Lazenby AJ, Bayless TM. The new colitides, Collagenous, lymphocytic, and diversion colitis. Gastroenterol Clin North Am 1995;24:717-29.
22. Rasmussen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease - microscopic colitis? Aliment Pharmacol Ther 2012; 36:79-90.
23. Munch A, Langner C. Microscopic colitis: clinical and pathologic perspectives. Clin Gastroenterol Hepatol 2015; 13:228-36.
24. Veress B, Lofberg R, Bergman L. Microscopic colitis syndrome. Gut 1995;36:880-6.
25. Miehlke S, Madisch A, Karimi D, Wonschik S, Kuhlisch E, Beckmann R, et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebocontrolled study. Gastroenterology 2009;136:2092-100.
26. Goranzon C, Kumawat AK, Hultgren-Hornqvist E, Tysk C, Eriksson S, Bohr J, et al. Immunohistochemical characterization of lymphocytes in microscopic colitis. J Crohns Colitis 2013;7:e434-42.
27. Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009;104:235-41; quiz 234, 242.